LAUREN DUGAN: Open Payments
NPI 1861257651 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,573 in 54 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $1,486 · 2025 $1,573
Food & beverage: $1,415Education: $158
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 25 | $668 |
| GENZYME CORPORATION | 7 | $312 |
| AstraZeneca Pharmaceuticals LP | 2 | $219 |
| Novartis Pharmaceuticals Corporation | 7 | $132 |
| CSL Behring | 3 | $63 |
| Amgen Inc. | 3 | $52 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Genentech USA, Inc. | 2 | $34 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, Rhapsido, Hizentra, Xolair, TRELEGY ELLIPTA, Andembry.
Industry payments across KY — which companies pay providers there.
